Infectious Disease — Medicare Part B billing by state
331 physician groups whose primary specialty is Infectious Disease billed $254.7M to Medicare fee-for-service in 2023.
Calendar year 2023 · Medicare fee-for-service Part B
You're viewing calendar year 2023. State market links open the latest data year.
On this page: Billing by state · Top codes
Medicare billing by state
| State | Standardized payments | Medicare payments | Groups | Pay / group | Services | Benef.-episodes | Svc / group |
|---|---|---|---|---|---|---|---|
| Florida | $53.4M | $53.9M | 81 | $666K | 11.6M | 231K | 144K |
| Texas | $35.9M | $35.4M | 48 | $738K | 2.7M | 136K | 55,720 |
| Illinois | $27.2M | $27.7M | 15 | $1.8M | 1.6M | 85,442 | 107K |
| New Jersey | $20.4M | $21.8M | 26 | $838K | 864K | 129K | 33,219 |
| Virginia | $19.0M | $18.8M | 10 | $1.9M | 1.1M | 23,830 | 112K |
| California | $17.4M | $18.5M | 31 | $596K | 468K | 59,618 | 15,085 |
| Michigan | $10.9M | $11.0M | 18 | $609K | 1.6M | 39,093 | 90,943 |
| Nevada | $7.1M | $7.1M | 14 | $507K | 1.3M | 32,385 | 90,212 |
| Georgia | $6.3M | $6.2M | 9 | $691K | 1.7M | 28,660 | 192K |
| New York | $5.4M | $5.9M | 23 | $257K | 113K | 28,757 | 4,917 |
| Arizona | $5.3M | $5.2M | 11 | $477K | 132K | 17,802 | 12,014 |
| Pennsylvania | $4.5M | $4.6M | 17 | $272K | 106K | 33,091 | 6,254 |
| Indiana | $4.1M | $4.1M | 3 | $1.4M | 154K | 8,471 | 51,319 |
| Missouri | $4.0M | $3.9M | 11 | $352K | 178K | 19,591 | 16,154 |
| Alabama | $3.7M | $3.5M | 8 | $442K | 250K | 15,354 | 31,258 |
| Colorado | $3.7M | $3.7M | 6 | $622K | 3.0M | 18,688 | 504K |
| Ohio | $3.0M | $2.9M | 8 | $367K | 41,765 | 18,444 | 5,221 |
| Maryland | $2.3M | $2.4M | 7 | $346K | 75,681 | 10,839 | 10,812 |
| Louisiana | $2.1M | $2.1M | 7 | $301K | 30,867 | 8,182 | 4,410 |
| Iowa | $1.9M | $1.9M | 2 | $932K | 40,130 | 1,014 | 20,065 |
| North Carolina | $1.7M | $1.6M | 6 | $273K | 36,943 | 16,517 | 6,157 |
| Kentucky | $1.7M | $1.6M | 6 | $267K | 563K | 9,680 | 93,908 |
| Kansas | $1.4M | $1.4M | 3 | $458K | 217K | 5,739 | 72,276 |
| Oklahoma | $1.4M | $1.3M | 5 | $264K | 99,334 | 8,408 | 19,867 |
| Tennessee | $1.1M | $1.0M | 7 | $150K | 17,116 | 6,348 | 2,445 |
| Delaware | $1.1M | $1.1M | 6 | $178K | 12,881 | 7,350 | 2,147 |
| Arkansas | $1.1M | $983K | 3 | $328K | 18,778 | 5,338 | 6,259 |
| South Carolina | $885K | $842K | 4 | $210K | 15,956 | 6,626 | 3,989 |
| Wyoming | $770K | $764K | 1 | $764K | 540K | 6,298 | 540K |
| Hawaii | $732K | $731K | 3 | $244K | 10,043 | 2,930 | 3,348 |
| Wisconsin | $617K | $609K | 4 | $152K | 11,843 | 1,381 | 2,961 |
| Nebraska | $514K | $479K | 2 | $239K | 58,370 | 3,291 | 29,185 |
| Massachusetts | $443K | $450K | 4 | $113K | 5,694 | 3,101 | 1,424 |
| New Mexico | $309K | $298K | 2 | $149K | 5,304 | 1,485 | 2,652 |
| Connecticut | $211K | $226K | 3 | $75K | 2,868 | 1,388 | 956 |
| West Virginia | $191K | $197K | 3 | $66K | 54,269 | 1,809 | 18,090 |
| Washington | $143K | $143K | 3 | $48K | 1,915 | 1,241 | 638 |
| Idaho | $84K | $75K | 2 | $37K | 893 | 361 | 446 |
| Minnesota | $62K | $62K | 2 | $31K | 662 | 254 | 331 |
| Maine | $28K | $26K | 1 | $26K | 409 | 262 | 409 |
| PR | $26K | $21K | 1 | $21K | 282 | 105 | 282 |
| Mississippi | $22K | $20K | 2 | $10K | 404 | 201 | 202 |
| District of Columbia | $12K | $13K | 1 | $13K | 170 | 122 | 170 |
| Rhode Island | $11K | $11K | 1 | $11K | 87 | 80 | 87 |
| South Dakota | $8K | $8K | 1 | $8K | 150 | 124 | 150 |
Need this specialty's market in one document?
Register your interestEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2023
6 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.
| Code | Medicare payments | Services | Largest state markets |
|---|---|---|---|
| J0897 · Injection, denosumab, 1 mg | $9.3M | 507K | FLTXILNJVA |
| J3245 · Injection, tildrakizumab, 1 mg | $8.2M | 75,100 | FLTXILNJVA |
| J3380 · Injection, vedolizumab, 1 mg | $7.4M | 428K | FLTXILNJVA |
| J0875 · Injection, dalbavancin, 5 mg | $6.2M | 526K | FLTXILNJVA |
| J1306 · Injection, inclisiran, 1 mg top by services | $2.7M | 284K | FLTXILNJVA |
| J3111 · Injection, romosozumab-aqqg, 1 mg top by services | $2.0M | 252K | FLTXILNJVA |
| J0485 · Injection, belatacept, 1 mg top by services | $1.4M | 492K | FLTXILNJVA |
| J0717 · Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) top by services | $1.0M | 264K | FLTXILNJVA |
| J0878 · Injection, daptomycin, 1 mg top by services | $884K | 21.7M | FLTXILNJVA |